Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and Immunogenicity
- Autores
- Williman, Joaquín; Tomás, Gonzalo; Vagnozzi, Ariel Eduardo; Techera, Claudia; Brambillasca, Sebastián; Pérez, Rubén; Marandino, Ana
- Año de publicación
- 2026
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background/Objectives: Serial passage in embryonated eggs is widely used to attenuate the infectious bronchitis virus (IBV) for vaccine production; however, the evolutionary processes underlying attenuation and immunogenicity remain incompletely understood. Here, we analyzed genome-wide viral evolution during serial passages to investigate how mutations emerge, persist, are lost, or become fixed over time and how these dynamics relate to changes in pathogenicity and immunogenicity. Methods: Deep sequencing was performed on 11 representative serial passages (P2–P79) of the UY/11/CA/18 strain, including two derivative lineages: P7 VIR (virulent) and P53 VAC (attenuated and immunogenic). Results: This study identified an early adaptive phase characterized by a limited set of mutations potentially associated with genome replication, viral RNA processing, and virion assembly, including a key change in non-structural protein 14 and variants in M and 3c (E). This phase was followed by a broader expansion of the variant spectrum across replicase genes and delayed accumulation of Spike protein variants. Most Spike changes emerged during later passages and exhibited transient dynamics, and only a subset reached a high frequency after the establishment of early replicase- and structural-associated changes. Consistent with these dynamics, P7 VIR diverged before the late accumulation of Spike variants and retained a pathogenic phenotype, whereas P53 VAC diverged after the emergence of early high-frequency variants but before the extensive late-stage Spike variation observed in P79, which was associated with reduced immunogenicity. Conclusions: These findings support a multi-step model of IBV attenuation in which progressive filtering of genome-wide variation shapes distinct evolutionary outcomes during serial passages. This evolutionary framework provides insight into the relationship between attenuation and immunogenicity and may help guide the rational design of live attenuated vaccines.
Instituto de Virología
Fil: Williman, Joaquín. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay
Fil: Tomás, Gonzalo. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay
Fil: Vagnozzi, Ariel Eduardo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología e Innovaciones Tecnológicas; Argentina
Fil: Vagnozzi, Ariel Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Techera, Claudia. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay
Fil: Brambillasca, Sebastián. Universidad de la República. Facultad de Veterinaria. Departamento de Producción Animal y Salud de los Sistemas Productivos. Unidad Académica de Avicultura; Uruguay
Fil: Pérez, Rubén. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay
Fil: Marandino, Ana. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay - Fuente
- Vaccines 14 (6) : 467. (June 2026)
- Materia
-
Enfermedades de los Animales
Vacuna
Inmunogenética
Bronquitis Infecciosa Aviar
Virus Bronquitis Infecciosa Aviar
Animal Diseases
Vaccines
Immunogenetics
Avian Infectious Bronchitis
Avian Infectious Bronchitis Virus - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by-nc-sa/4.0/
- Repositorio
.jpg)
- Institución
- Instituto Nacional de Tecnología Agropecuaria
- OAI Identificador
- oai:localhost:20.500.12123/27833
Ver los metadatos del registro completo
| id |
INTADig_de3f8b6d00efbb385d6f05707f4459e7 |
|---|---|
| oai_identifier_str |
oai:localhost:20.500.12123/27833 |
| network_acronym_str |
INTADig |
| repository_id_str |
l |
| network_name_str |
INTA Digital (INTA) |
| spelling |
Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and ImmunogenicityWilliman, JoaquínTomás, GonzaloVagnozzi, Ariel EduardoTechera, ClaudiaBrambillasca, SebastiánPérez, RubénMarandino, AnaEnfermedades de los AnimalesVacunaInmunogenéticaBronquitis Infecciosa AviarVirus Bronquitis Infecciosa AviarAnimal DiseasesVaccinesImmunogeneticsAvian Infectious BronchitisAvian Infectious Bronchitis VirusBackground/Objectives: Serial passage in embryonated eggs is widely used to attenuate the infectious bronchitis virus (IBV) for vaccine production; however, the evolutionary processes underlying attenuation and immunogenicity remain incompletely understood. Here, we analyzed genome-wide viral evolution during serial passages to investigate how mutations emerge, persist, are lost, or become fixed over time and how these dynamics relate to changes in pathogenicity and immunogenicity. Methods: Deep sequencing was performed on 11 representative serial passages (P2–P79) of the UY/11/CA/18 strain, including two derivative lineages: P7 VIR (virulent) and P53 VAC (attenuated and immunogenic). Results: This study identified an early adaptive phase characterized by a limited set of mutations potentially associated with genome replication, viral RNA processing, and virion assembly, including a key change in non-structural protein 14 and variants in M and 3c (E). This phase was followed by a broader expansion of the variant spectrum across replicase genes and delayed accumulation of Spike protein variants. Most Spike changes emerged during later passages and exhibited transient dynamics, and only a subset reached a high frequency after the establishment of early replicase- and structural-associated changes. Consistent with these dynamics, P7 VIR diverged before the late accumulation of Spike variants and retained a pathogenic phenotype, whereas P53 VAC diverged after the emergence of early high-frequency variants but before the extensive late-stage Spike variation observed in P79, which was associated with reduced immunogenicity. Conclusions: These findings support a multi-step model of IBV attenuation in which progressive filtering of genome-wide variation shapes distinct evolutionary outcomes during serial passages. This evolutionary framework provides insight into the relationship between attenuation and immunogenicity and may help guide the rational design of live attenuated vaccines.Instituto de VirologíaFil: Williman, Joaquín. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; UruguayFil: Tomás, Gonzalo. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; UruguayFil: Vagnozzi, Ariel Eduardo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología e Innovaciones Tecnológicas; ArgentinaFil: Vagnozzi, Ariel Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Techera, Claudia. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; UruguayFil: Brambillasca, Sebastián. Universidad de la República. Facultad de Veterinaria. Departamento de Producción Animal y Salud de los Sistemas Productivos. Unidad Académica de Avicultura; UruguayFil: Pérez, Rubén. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; UruguayFil: Marandino, Ana. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; UruguayMDPI2026-09-17T13:21:18Z2026-09-17T13:21:18Z2026-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/20.500.12123/27833https://www.mdpi.com/2076-393X/14/6/4672076-393Xhttps://doi.org/10.3390/vaccines14060467Vaccines 14 (6) : 467. (June 2026)reponame:INTA Digital (INTA)instname:Instituto Nacional de Tecnología Agropecuariaenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)2026-09-24T11:43:50Zoai:localhost:20.500.12123/27833instacron:INTAInstitucionalhttp://repositorio.inta.gob.ar/Organismo científico-tecnológicoNo correspondehttp://repositorio.inta.gob.ar/oai/requesttripaldi.nicolas@inta.gob.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:l2026-09-24 11:43:51.555INTA Digital (INTA) - Instituto Nacional de Tecnología Agropecuariafalse |
| dc.title.none.fl_str_mv |
Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and Immunogenicity |
| title |
Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and Immunogenicity |
| spellingShingle |
Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and Immunogenicity Williman, Joaquín Enfermedades de los Animales Vacuna Inmunogenética Bronquitis Infecciosa Aviar Virus Bronquitis Infecciosa Aviar Animal Diseases Vaccines Immunogenetics Avian Infectious Bronchitis Avian Infectious Bronchitis Virus |
| title_short |
Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and Immunogenicity |
| title_full |
Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and Immunogenicity |
| title_fullStr |
Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and Immunogenicity |
| title_full_unstemmed |
Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and Immunogenicity |
| title_sort |
Genome-Wide Analysis of Serial Passage of the Infectious Bronchitis Virus Reveals Evolutionary Dynamics Underlying Attenuation and Immunogenicity |
| dc.creator.none.fl_str_mv |
Williman, Joaquín Tomás, Gonzalo Vagnozzi, Ariel Eduardo Techera, Claudia Brambillasca, Sebastián Pérez, Rubén Marandino, Ana |
| author |
Williman, Joaquín |
| author_facet |
Williman, Joaquín Tomás, Gonzalo Vagnozzi, Ariel Eduardo Techera, Claudia Brambillasca, Sebastián Pérez, Rubén Marandino, Ana |
| author_role |
author |
| author2 |
Tomás, Gonzalo Vagnozzi, Ariel Eduardo Techera, Claudia Brambillasca, Sebastián Pérez, Rubén Marandino, Ana |
| author2_role |
author author author author author author |
| dc.subject.none.fl_str_mv |
Enfermedades de los Animales Vacuna Inmunogenética Bronquitis Infecciosa Aviar Virus Bronquitis Infecciosa Aviar Animal Diseases Vaccines Immunogenetics Avian Infectious Bronchitis Avian Infectious Bronchitis Virus |
| topic |
Enfermedades de los Animales Vacuna Inmunogenética Bronquitis Infecciosa Aviar Virus Bronquitis Infecciosa Aviar Animal Diseases Vaccines Immunogenetics Avian Infectious Bronchitis Avian Infectious Bronchitis Virus |
| dc.description.none.fl_txt_mv |
Background/Objectives: Serial passage in embryonated eggs is widely used to attenuate the infectious bronchitis virus (IBV) for vaccine production; however, the evolutionary processes underlying attenuation and immunogenicity remain incompletely understood. Here, we analyzed genome-wide viral evolution during serial passages to investigate how mutations emerge, persist, are lost, or become fixed over time and how these dynamics relate to changes in pathogenicity and immunogenicity. Methods: Deep sequencing was performed on 11 representative serial passages (P2–P79) of the UY/11/CA/18 strain, including two derivative lineages: P7 VIR (virulent) and P53 VAC (attenuated and immunogenic). Results: This study identified an early adaptive phase characterized by a limited set of mutations potentially associated with genome replication, viral RNA processing, and virion assembly, including a key change in non-structural protein 14 and variants in M and 3c (E). This phase was followed by a broader expansion of the variant spectrum across replicase genes and delayed accumulation of Spike protein variants. Most Spike changes emerged during later passages and exhibited transient dynamics, and only a subset reached a high frequency after the establishment of early replicase- and structural-associated changes. Consistent with these dynamics, P7 VIR diverged before the late accumulation of Spike variants and retained a pathogenic phenotype, whereas P53 VAC diverged after the emergence of early high-frequency variants but before the extensive late-stage Spike variation observed in P79, which was associated with reduced immunogenicity. Conclusions: These findings support a multi-step model of IBV attenuation in which progressive filtering of genome-wide variation shapes distinct evolutionary outcomes during serial passages. This evolutionary framework provides insight into the relationship between attenuation and immunogenicity and may help guide the rational design of live attenuated vaccines. Instituto de Virología Fil: Williman, Joaquín. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay Fil: Tomás, Gonzalo. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay Fil: Vagnozzi, Ariel Eduardo. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología e Innovaciones Tecnológicas; Argentina Fil: Vagnozzi, Ariel Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Techera, Claudia. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay Fil: Brambillasca, Sebastián. Universidad de la República. Facultad de Veterinaria. Departamento de Producción Animal y Salud de los Sistemas Productivos. Unidad Académica de Avicultura; Uruguay Fil: Pérez, Rubén. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay Fil: Marandino, Ana. Universidad de la República. Facultad de Ciencias. Instituto de Biología. Departamento de Biología Animal. Sección Genética Evolutiva; Uruguay |
| description |
Background/Objectives: Serial passage in embryonated eggs is widely used to attenuate the infectious bronchitis virus (IBV) for vaccine production; however, the evolutionary processes underlying attenuation and immunogenicity remain incompletely understood. Here, we analyzed genome-wide viral evolution during serial passages to investigate how mutations emerge, persist, are lost, or become fixed over time and how these dynamics relate to changes in pathogenicity and immunogenicity. Methods: Deep sequencing was performed on 11 representative serial passages (P2–P79) of the UY/11/CA/18 strain, including two derivative lineages: P7 VIR (virulent) and P53 VAC (attenuated and immunogenic). Results: This study identified an early adaptive phase characterized by a limited set of mutations potentially associated with genome replication, viral RNA processing, and virion assembly, including a key change in non-structural protein 14 and variants in M and 3c (E). This phase was followed by a broader expansion of the variant spectrum across replicase genes and delayed accumulation of Spike protein variants. Most Spike changes emerged during later passages and exhibited transient dynamics, and only a subset reached a high frequency after the establishment of early replicase- and structural-associated changes. Consistent with these dynamics, P7 VIR diverged before the late accumulation of Spike variants and retained a pathogenic phenotype, whereas P53 VAC diverged after the emergence of early high-frequency variants but before the extensive late-stage Spike variation observed in P79, which was associated with reduced immunogenicity. Conclusions: These findings support a multi-step model of IBV attenuation in which progressive filtering of genome-wide variation shapes distinct evolutionary outcomes during serial passages. This evolutionary framework provides insight into the relationship between attenuation and immunogenicity and may help guide the rational design of live attenuated vaccines. |
| publishDate |
2026 |
| dc.date.none.fl_str_mv |
2026-09-17T13:21:18Z 2026-09-17T13:21:18Z 2026-06 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12123/27833 https://www.mdpi.com/2076-393X/14/6/467 2076-393X https://doi.org/10.3390/vaccines14060467 |
| url |
http://hdl.handle.net/20.500.12123/27833 https://www.mdpi.com/2076-393X/14/6/467 https://doi.org/10.3390/vaccines14060467 |
| identifier_str_mv |
2076-393X |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
Vaccines 14 (6) : 467. (June 2026) reponame:INTA Digital (INTA) instname:Instituto Nacional de Tecnología Agropecuaria |
| reponame_str |
INTA Digital (INTA) |
| collection |
INTA Digital (INTA) |
| instname_str |
Instituto Nacional de Tecnología Agropecuaria |
| repository.name.fl_str_mv |
INTA Digital (INTA) - Instituto Nacional de Tecnología Agropecuaria |
| repository.mail.fl_str_mv |
tripaldi.nicolas@inta.gob.ar |
| _version_ |
1877227358997446656 |
| score |
13.265058 |